Clinical Trials Browser

OTHER × Purpura, Thrombocytopenic, Idiopathic × Clear all

NCT06444477 2026-01-26

MATAC

Neoplasms, Purpura, Thrombocytopenic, Idiopathic

NCT02422875 2025-09-30

Comparative Autoantibody and Immunologic Cell Marker Study

Enrolling by invitation

Undifferentiated Connective Tissue Diseases, Immunoglobulin G4-Related Disease, Acquired Immunodeficiency Syndrome, Arthritis, Arthritis, Juvenile, Arthritis, Rheumatoid, Autoimmune Diseases, Communicable Diseases, Graft vs Host Disease, Hepatitis C, Lupus Erythematosus, Systemic, Myositis, Sjogren's Syndrome, Purpura, Thrombocytopenic, Idiopathic, Sepsis, Epstein-Barr Virus Infections, Guillain-Barre Syndrome, Scleroderma, Diffuse, Autoimmune Lymphoproliferative Syndrome

NCT06873672 2025-03-13

Validation of the EQ-5D-Y-3L and EQ-5D-Y-5L for Paediatric Patients in China

Not yet recruiting

CNSGenitourinary

Wilms Tumor, Neuroblastoma, Purpura, Thrombocytopenic, Idiopathic

NCT05393999 2023-04-24

SABRE

Phase 2 Withdrawn

LymphoidOther hematologic neoplasmPlasma cell

COVID-19, Leukemia, Lymphoma, Purpura, Thrombotic Thrombocytopenic, Purpura, Thrombocytopenic, Idiopathic, Neoplasms, Plasma Cell

NCT05328804 2022-04-26

Herombopag + rhTPO in Severe Immune Thrombocytopenia

Phase 3 Unknown

Lymphoma, Follicular, Purpura, Thrombocytopenic, Idiopathic

NCT01610180 2018-07-16

Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs)

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Purpura, Thrombocytopenic, Idiopathic